Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$53.63 - $62.52 $645,329 - $752,303
-12,033 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$59.17 - $69.31 $243,721 - $285,487
-4,119 Reduced 25.5%
12,033 $712,000
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $3,714 - $4,045
60 Added 0.37%
16,152 $1.08 Million
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $72,335 - $81,356
1,219 Added 8.2%
16,092 $1.02 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $56,931 - $64,513
-986 Reduced 6.22%
14,873 $927,000
Q3 2020

Oct 13, 2020

SELL
$57.43 - $63.64 $107,279 - $118,879
-1,868 Reduced 10.54%
15,859 $938,000
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $7,619 - $8,908
-139 Reduced 0.78%
17,727 $1.06 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $39,486 - $57,382
851 Added 5.0%
17,866 $1.04 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $17,518 - $22,851
356 Added 2.14%
17,015 $1.09 Million
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $124,417 - $147,515
-2,909 Reduced 14.87%
16,659 $845,000
Q2 2019

Jul 22, 2019

SELL
$44.62 - $49.34 $94,237 - $104,206
-2,112 Reduced 9.74%
19,568 $887,000
Q1 2019

Apr 15, 2019

SELL
$45.12 - $53.8 $49,857 - $59,449
-1,105 Reduced 4.85%
21,680 $1.03 Million
Q4 2018

Jan 24, 2019

SELL
$48.76 - $63.23 $356,923 - $462,843
-7,320 Reduced 24.31%
22,785 $1.18 Million
Q3 2018

Oct 18, 2018

BUY
$55.19 - $62.25 $32,506 - $36,665
589 Added 2.0%
30,105 $1.87 Million
Q2 2018

Jul 30, 2018

SELL
$50.53 - $62.98 $148,153 - $184,657
-2,932 Reduced 9.04%
29,516 $1.63 Million
Q1 2018

Apr 19, 2018

SELL
$59.92 - $68.98 $96,591 - $111,195
-1,612 Reduced 4.73%
32,448 $2.05 Million
Q4 2017

Jan 16, 2018

SELL
$59.94 - $65.35 $156,683 - $170,824
-2,614 Reduced 7.13%
34,060 $2.09 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $62,630 - $72,281
-1,134 Reduced 3.0%
36,674 $2.34 Million
Q2 2017

Aug 10, 2017

BUY
N/A
37,808
37,808 $2.11 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Strategic Advisors LLC Portfolio

Follow Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.